Literature DB >> 18265012

Cardiac malformations and myocardial abnormalities in podoplanin knockout mouse embryos: Correlation with abnormal epicardial development.

Edris A F Mahtab1, Maurits C E F Wijffels, Nynke M S Van Den Akker, Nathan D Hahurij, Heleen Lie-Venema, Lambertus J Wisse, Marco C Deruiter, Pavel Uhrin, Jan Zaujec, Bernd R Binder, Martin J Schalij, Robert E Poelmann, Adriana C Gittenberger-De Groot.   

Abstract

Epicardium and epicardium-derived cells have been shown to be necessary for myocardial differentiation. To elucidate the function of podoplanin in epicardial development and myocardial differentiation, we analyzed podoplanin knockout mouse embryos between embryonic day (E) 9.5 and E15.5 using immunohistochemical differentiation markers, morphometry, and three-dimensional reconstructions. Podoplanin null mice have an increased embryonic lethality, possibly of cardiac origin. Our study reveals impairment in the development of the proepicardial organ, epicardial adhesion, and spreading and migration of the epicardium-derived cells. Mutant embryos show a hypoplastic and perforated compact and septal myocardium, hypoplastic atrioventricular cushions resulting in atrioventricular valve abnormalities, as well as coronary artery abnormalities. The epicardial pathology is correlated with reduced epithelial-mesenchymal transformation caused by up-regulation of E-cadherin, normally down-regulated by podoplanin. Our results demonstrate a role for podoplanin in normal cardiac development based on epicardial-myocardial interaction. Abnormal epicardial differentiation and reduced epithelial-mesenchymal transformation result in deficient epicardium-derived cells leading to myocardial pathology and cardiac anomalies. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18265012     DOI: 10.1002/dvdy.21463

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  52 in total

1.  Pod1/Tcf21 is regulated by retinoic acid signaling and inhibits differentiation of epicardium-derived cells into smooth muscle in the developing heart.

Authors:  Caitlin M Braitsch; Michelle D Combs; Susan E Quaggin; Katherine E Yutzey
Journal:  Dev Biol       Date:  2012-06-09       Impact factor: 3.582

Review 2.  Epicardial-myocardial signaling directing coronary vasculogenesis.

Authors:  Harold E Olivey; Eric C Svensson
Journal:  Circ Res       Date:  2010-03-19       Impact factor: 17.367

3.  Epicardial spindle orientation controls cell entry into the myocardium.

Authors:  Mingfu Wu; Christopher L Smith; James A Hall; Ivy Lee; Kate Luby-Phelps; Michelle D Tallquist
Journal:  Dev Cell       Date:  2010-07-20       Impact factor: 12.270

Review 4.  Developmental origins of hypertrophic cardiomyopathy phenotypes: a unifying hypothesis.

Authors:  Iacopo Olivotto; Franco Cecchi; Corrado Poggesi; Magdi H Yacoub
Journal:  Nat Rev Cardiol       Date:  2009-04       Impact factor: 32.419

5.  ALK1 signaling regulates early postnatal lymphatic vessel development.

Authors:  Kyle Niessen; Gu Zhang; John Brady Ridgway; Hao Chen; Minhong Yan
Journal:  Blood       Date:  2009-11-10       Impact factor: 22.113

Review 6.  Origin of cardiac fibroblasts and the role of periostin.

Authors:  Paige Snider; Kara N Standley; Jian Wang; Mohamad Azhar; Thomas Doetschman; Simon J Conway
Journal:  Circ Res       Date:  2009-11-06       Impact factor: 17.367

Review 7.  Coronary vessel development and insight towards neovascular therapy.

Authors:  Nicola Smart; Karina N Dubé; Paul R Riley
Journal:  Int J Exp Pathol       Date:  2009-06       Impact factor: 1.925

Review 8.  Podoplanin: a novel regulator of tumor invasion and metastasis.

Authors:  Qi Dang; Jie Liu; Juan Li; Yuping Sun
Journal:  Med Oncol       Date:  2014-08-21       Impact factor: 3.064

Review 9.  Podoplanin--a novel marker in oral carcinogenesis.

Authors:  Niharika Swain; Shwetha V Kumar; Samapika Routray; Jigna Pathak; Shilpa Patel
Journal:  Tumour Biol       Date:  2014-06-27

Review 10.  Podoplanin - a small glycoprotein with many faces.

Authors:  Maciej Ugorski; Piotr Dziegiel; Jaroslaw Suchanski
Journal:  Am J Cancer Res       Date:  2016-01-15       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.